Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Haemoglobinopathies Market: By Type: Thalassemia, Sickle Cell Disease; By Test Type: Routine Red Blood Cell (RBC) Count, Genetic Testing; By End Use; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Value Chain Analysis; Manufacturing Process; Competitive Landscape; Industry Events and Developments

Global Haemoglobinopathies Market Outlook

The global haemoglobinopathies market is expected to grow at a CAGR of 7.8% in the forecast period of 2023-2028.

 

Global Haemoglobinopathies Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The Asia Pacific is Expected to Provide Enhanced Growth Opportunities for the Haemoglobinopathies Industry

North America significantly contributes to the growth of the industry owing to the presence of advanced healthcare facilities, better reimbursement policies, and growing R&D activities in the region. The growing prevalence of haemoglobinopathies in European countries, particularly Germany, is also contributing to the industry growth. Meanwhile, the Asia Pacific is expected to witness a healthy growth over the forecast period owing to the unmet needs of the patients suffering from haemoglobinopathies. The growing awareness regarding haemoglobinopathies, improving healthcare infrastructures, and favourable government initiatives are propelling the market growth in the Asia Pacific.

 

Haemoglobinopathies: Market Segmentation

Haemoglobinopathies refer to a group of genetic disorders that affect red blood cells or the structure or production of the haemoglobin molecule. Encompassing all genetic diseases of haemoglobin, hemoglobinopathies are the most common monogenic diseases. They fall into two main groups, namely, thalassemia syndromes and structural haemoglobin variants (abnormal haemoglobins). The clinical manifestations of these disorders are highly variable and can range from mild hypochromic anaemia to moderate haematological disease to severe, lifelong, transfusion-dependent anaemia having multiorgan involvement.

 

Global Haemoglobinopathies Market By Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on type, the market is divided into:

  • Thalassemia
  • Sickle Cell Disease
  • Others

Among these, the thalassemia segment is further bifurcated into alpha thalassemia and beta thalassemia on the basis of type

On the basis of test type, the industry can be segmented into:

  • Routine Red Blood Cell (RBC) Count
  • Genetic Testing
  • Haemoglobin by High Performance Liquid Chromatography
  • Haemoglobin Isoelectric Focusing (Hb IEF)
  • Haemoglobin Electrophoresis (Hb ELP)
  • Haemoglobin Solubility Test
  • Others

Based on end use, the industry can be categorised into:

  • Hospitals
  • Diagnostics Laboratories
  • Clinics
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Haemoglobinopathies Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Prevalence of Haemoglobinopathies and Increasing Diagnostic Facilities to Bolster the Haemoglobinopathies Industry Growth

The rising incidences of haemoglobinopathies across the globe and the increasing health awareness are driving the growth of the global market for haemoglobinopathies. The market is being supported by the favourable government initiatives to create awareness regarding haemoglobinopathies and the presence of improved diagnostic facilities, particularly in developing nations. Other factors like the growing adoption of Big Data and AI in the healthcare sector, growing focus on patient care, and growing healthcare infrastructures are further propelling the market growth. Over the forecast period, the growing R&D activities are expected to have a positive effect on the expansion of the global haemoglobinopathies industry.

 

Key Industry Players in the Global Haemoglobinopathies Market

The report gives a detailed analysis of the following key players in the global haemoglobinopathies market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Sanofi
  • Bluebird Bio, Inc.
  • Emmaus Medical, Inc.
  • Prolong Pharmaceuticals, LLC.
  • Global Blood Therapeutics, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Test Type, End Use, Region
Breakup by Type Thalassemia, Sickle Cell Disease, Others
Breakup by Test Type Routine Red Blood Cell (RBC) Count, Genetic Testing, Haemoglobin
by High Performance Liquid Chromatography, Haemoglobin Isoelectric
Focusing (Hb IEF), Haemoglobin Electrophoresis (Hb ELP), Haemoglobin Solubility Test, Others
Breakup by End Use Hospitals, Diagnostics Laboratories, Clinics, Others
Breakup by Region North America, Latin America, Europe, Middle East and Africa, Asia Pacific
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Sanofi, Bluebird Bio, Inc., Emmaus Medical, Inc., Prolong Pharmaceuticals, LLC., Global Blood Therapeutics, Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Haemoglobinopathies Market Analysis
    8.1    Key Industry Highlights
    8.2    Global Haemoglobinopathies Historical Market (2018-2022) 
    8.3    Global Haemoglobinopathies Market Forecast (2023-2028)
    8.4    Global Haemoglobinopathies Market by Type
        8.4.1    Thalassemia
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    Alpha Thalassemia
                    8.4.1.4.1.1    Market Share
                    8.4.1.4.1.2    Historical Trend (2018-2022)
                    8.4.1.4.1.3    Forecast Trend (2023-2028)
                8.4.1.4.2    Beta Thalassemia
                    8.4.1.4.2.1    Market Share
                    8.4.1.4.2.2    Historical Trend (2018-2022)
                    8.4.1.4.2.3    Forecast Trend (2023-2028)
        8.4.2    Sickle Cell Disease
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Others
    8.5    Global Haemoglobinopathies Market by Test Type
        8.5.1    Routine Red Blood Cell (RBC) Count
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Genetic Testing
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Haemoglobin by High Performance Liquid Chromatography
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Haemoglobin Isoelectric Focusing (Hb IEF)
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2018-2022)
            8.5.4.3    Forecast Trend (2023-2028)
        8.5.5    Haemoglobin Electrophoresis (Hb ELP)
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2018-2022)
            8.5.5.3    Forecast Trend (2023-2028)
        8.5.6    Haemoglobin Solubility Test
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2018-2022)
            8.5.6.3    Forecast Trend (2023-2028)
        8.5.7    Others
    8.6    Global Haemoglobinopathies Market by End Use
        8.6.1    Hospitals
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Diagnostics Laboratories
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Clinics
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022)
            8.6.3.3    Forecast Trend (2023-2028)
        8.6.4    Others
    8.7    Global Haemoglobinopathies Market by Region       
        8.7.1    North America
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2022) 
            8.7.1.3    Forecast Trend (2023-2028)
        8.7.2    Europe
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2022) 
            8.7.2.3    Forecast Trend (2023-2028)
        8.7.3    Asia Pacific
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2018-2022) 
            8.7.3.3    Forecast Trend (2023-2028)
        8.7.4    Latin America
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2018-2022) 
            8.7.4.3    Forecast Trend (2023-2028)
        8.7.5    Middle East and Africa
            8.7.5.1    Market Share
            8.7.5.2    Historical Trend (2018-2022) 
            8.7.5.3    Forecast Trend (2023-2028) 
9    North America Haemoglobinopathies Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Haemoglobinopathies Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Haemoglobinopathies Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Haemoglobinopathies Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Haemoglobinopathies Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Sanofi
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Bluebird Bio, Inc.
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Emmaus Medical, Inc.
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Prolong Pharmaceuticals, LLC.
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Global Blood Therapeutics, Inc.
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Others
17    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Haemoglobinopathies Market: Key Industry Highlights, 2016 and 2026
2.    Global Haemoglobinopathies Historical Market: Breakup by Form (USD Million), 2018-2022
3.    Global Haemoglobinopathies Market Forecast: Breakup by Form (USD Million), 2023-2028
4.    Global Haemoglobinopathies Historical Market: Breakup by Application (USD Million), 2018-2022
5.    Global Haemoglobinopathies Market Forecast: Breakup by Application (USD Million), 2023-2028
6.    Global Haemoglobinopathies Historical Market: Breakup by Region (USD Million), 2018-2022
7.    Global Haemoglobinopathies Market Forecast: Breakup by Region (USD Million), 2023-2028
8.    North America Haemoglobinopathies Historical Market: Breakup by Country (USD Million), 2018-2022
9.    North America Haemoglobinopathies Market Forecast: Breakup by Country (USD Million), 2023-2028
10.    Europe Haemoglobinopathies Historical Market: Breakup by Country (USD Million), 2018-2022
11.    Europe Haemoglobinopathies Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Asia Pacific Haemoglobinopathies Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Asia Pacific Haemoglobinopathies Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Latin America Haemoglobinopathies Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Latin America Haemoglobinopathies Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Middle East and Africa Haemoglobinopathies Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Middle East and Africa Haemoglobinopathies Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Global Haemoglobinopathies Market Structure

Key Questions Answered in the Report

The global haemoglobinopathies market is projected to grow at a CAGR of 7.8% between 2021 and 2026.

The major drivers of the industry, such as the increasing health awareness, growing prevalence of haemoglobinopathies, favourable government initiatives, and advancements in medical sector, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing R&D activities and the rapid technological advancements in the healthcare sector.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading types of haemoglobinopathies in the market are thalassemia and sickle cell disease, among others.

The major test types in the industry are routine red blood cell (RBC) count, genetic testing, haemoglobin by high performance liquid chromatography, haemoglobin isoelectric focusing (Hb IEF), haemoglobin electrophoresis (Hb ELP), and haemoglobin solubility test, among others.

The significant end use sectors in the market are hospitals, diagnostics laboratories, and clinics, among others.

The major players in the industry are Sanofi, Bluebird Bio, Inc., Emmaus Medical, Inc., Prolong Pharmaceuticals, LLC., and Global Blood Therapeutics, Inc., among others.

Analyst Review

The global haemoglobinopathies market is being driven by the rising prevalence of haemoglobinopathies. Aided by the technological advancements, the market is expected to witness a healthy growth in the forecast period of 2023-2028, growing at a CAGR of 7.8%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By type, the market is segmented into thalassemia and sickle cell disease, among others. Based on test type, the industry is divided into routine red blood cell (RBC) count, genetic testing, haemoglobin by high performance liquid chromatography, haemoglobin isoelectric focusing (Hb IEF), haemoglobin electrophoresis (Hb ELP), and haemoglobin solubility test, among others. On the basis of end use, the market is divided into hospitals, diagnostics laboratories, and clinics, among others. The major regional markets for haemoglobinopathies are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Sanofi, Bluebird Bio, Inc., Emmaus Medical, Inc., Prolong Pharmaceuticals, LLC., and Global Blood Therapeutics, Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER